Sukhtian Faisal Ghiath

Track

Insider profile

Performance

Overall performance
3.8
Performance over holding periods
3.8
30 days 90 days 120 days
Average return 51% 8.2% 15.1%
Success rate 42% 68% 82%
Transactions
6 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Sukhtian Faisal Ghiath's trades of Outlook Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
133.12
Quantity 31,593 -8.6%
Value US$3,709,237
Transaction date
Purchase
Price
301.63
Quantity 93,546 -36.9%
Value US$208,620
Transaction date
Purchase
Price
1.40
Quantity 18,000 +90.0%
Value US$25,200
Transaction date
Purchase
Price
1.82
Quantity 10,000 +100.0%
Value US$18,200
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-29 2026-07-29
B Purchase
31,593 -8.6%
133.12
US$3,709,237 		31,593 -8.6% 133.12 US$3,709,237
2026-05-27 2026-05-27
B Purchase
93,546 -36.9%
301.63
US$208,620 		93,546 -36.9% 301.63 US$208,620
2022-10-11 2022-10-07
B Purchase
91,435 +10.6%
455.84
US$3,887,833 		91,435 +10.6% 455.84 US$3,887,833
2021-12-02 2021-12-02
B Purchase
18,000 +90.0%
1.40
US$25,200 		18,000 +90.0% 1.40 US$25,200
2021-04-20 2021-04-19
B Purchase
10,000 +100.0%
1.82
US$18,200 		10,000 +100.0% 1.82 US$18,200
2020-09-17 2020-09-17
B Purchase
10,000 +inf%
0.67
US$6,731 		10,000 +inf% 0.67 US$6,731